678 related articles for article (PubMed ID: 19560924)
1. Functionalized 3-amino-imidazo[1,2-a]pyridines: a novel class of drug-like Mycobacterium tuberculosis glutamine synthetase inhibitors.
Odell LR; Nilsson MT; Gising J; Lagerlund O; Muthas D; Nordqvist A; Karlén A; Larhed M
Bioorg Med Chem Lett; 2009 Aug; 19(16):4790-3. PubMed ID: 19560924
[TBL] [Abstract][Full Text] [Related]
2. Nanomolar inhibitors of Mycobacterium tuberculosis glutamine synthetase 1: synthesis, biological evaluation and X-ray crystallographic studies.
Couturier C; Silve S; Morales R; Pessegue B; Llopart S; Nair A; Bauer A; Scheiper B; Pöverlein C; Ganzhorn A; Lagrange S; Bacqué E
Bioorg Med Chem Lett; 2015 Apr; 25(7):1455-9. PubMed ID: 25770781
[TBL] [Abstract][Full Text] [Related]
3. Structural basis for the inhibition of Mycobacterium tuberculosis glutamine synthetase by novel ATP-competitive inhibitors.
Nilsson MT; Krajewski WW; Yellagunda S; Prabhumurthy S; Chamarahally GN; Siddamadappa C; Srinivasa BR; Yahiaoui S; Larhed M; Karlén A; Jones TA; Mowbray SL
J Mol Biol; 2009 Oct; 393(2):504-13. PubMed ID: 19695264
[TBL] [Abstract][Full Text] [Related]
4. Bisphosphonic acids as effective inhibitors of Mycobacterium tuberculosis glutamine synthetase.
Kosikowska P; Bochno M; Macegoniuk K; Forlani G; Kafarski P; Berlicki Ł
J Enzyme Inhib Med Chem; 2016 Dec; 31(6):931-8. PubMed ID: 26235917
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and some reactions of 1-methyl-1H-2-cyanomethyl-imidazo[4,5-b]pyridine. Tuberculostatic activity of obtained compounds.
Bukowski L; Janowiec M
Pharmazie; 1990 Dec; 45(12):904-7. PubMed ID: 2129248
[TBL] [Abstract][Full Text] [Related]
6. IRAK-4 inhibitors. Part II: a structure-based assessment of imidazo[1,2-a]pyridine binding.
Buckley GM; Ceska TA; Fraser JL; Gowers L; Groom CR; Higueruelo AP; Jenkins K; Mack SR; Morgan T; Parry DM; Pitt WR; Rausch O; Richard MD; Sabin V
Bioorg Med Chem Lett; 2008 Jun; 18(11):3291-5. PubMed ID: 18482836
[TBL] [Abstract][Full Text] [Related]
7. Design, synthesis, and activity of analogues of phosphinothricin as inhibitors of glutamine synthetase.
Berlicki Ł; Obojska A; Forlani G; Kafarski P
J Med Chem; 2005 Oct; 48(20):6340-9. PubMed ID: 16190760
[TBL] [Abstract][Full Text] [Related]
8. Trisubstituted imidazoles as Mycobacterium tuberculosis glutamine synthetase inhibitors.
Gising J; Nilsson MT; Odell LR; Yahiaoui S; Lindh M; Iyer H; Sinha AM; Srinivasa BR; Larhed M; Mowbray SL; Karlén A
J Med Chem; 2012 Mar; 55(6):2894-8. PubMed ID: 22369127
[TBL] [Abstract][Full Text] [Related]
9. Design, synthesis and antimycobacterial activity of some novel imidazo[1,2-c]pyrimidines.
Chhabria MT; Jani MH
Eur J Med Chem; 2009 Oct; 44(10):3837-44. PubMed ID: 19423196
[TBL] [Abstract][Full Text] [Related]
10. Computational Sampling and Simulation Based Assessment of Novel Mycobacterium tuberculosis Glutamine Synthetase Inhibitors: Study Involving Structure Based Drug Design and Free Energy Perturbation.
Suryadevara P; Yogeeswari P; Soni V; Devi PB; Nandicoori VK; Sriram D
Curr Top Med Chem; 2016; 16(9):978-95. PubMed ID: 26303425
[TBL] [Abstract][Full Text] [Related]
11. Aminoimidazo[1,2-a]pyridines as a new structural class of cyclin-dependent kinase inhibitors. Part 1: Design, synthesis, and biological evaluation.
Jaramillo C; de Diego JE; Hamdouchi C; Collins E; Keyser H; Sánchez-Martínez C; del Prado M; Norman B; Brooks HB; Watkins SA; Spencer CD; Dempsey JA; Anderson BD; Campbell RM; Leggett T; Patel B; Schultz RM; Espinosa J; Vieth M; Zhang F; Timm DE
Bioorg Med Chem Lett; 2004 Dec; 14(24):6095-9. PubMed ID: 15546737
[TBL] [Abstract][Full Text] [Related]
12. A discovery of novel Mycobacterium tuberculosis pantothenate synthetase inhibitors based on the molecular mechanism of actinomycin D inhibition.
Yang Y; Gao P; Liu Y; Ji X; Gan M; Guan Y; Hao X; Li Z; Xiao C
Bioorg Med Chem Lett; 2011 Jul; 21(13):3943-6. PubMed ID: 21641210
[TBL] [Abstract][Full Text] [Related]
13. Some reactions of 2-cyanomethyl-3-methyl-3H-imidazo[4,5-b]pyridine with isothiocyanates. Antituberculotic activity of the obtained compounds.
Bukowski L
Pharmazie; 2001 Jan; 56(1):23-7. PubMed ID: 11210662
[TBL] [Abstract][Full Text] [Related]
14. Lead optimization of a novel series of imidazo[1,2-a]pyridine amides leading to a clinical candidate (Q203) as a multi- and extensively-drug-resistant anti-tuberculosis agent.
Kang S; Kim RY; Seo MJ; Lee S; Kim YM; Seo M; Seo JJ; Ko Y; Choi I; Jang J; Nam J; Park S; Kang H; Kim HJ; Kim J; Ahn S; Pethe K; Nam K; No Z; Kim J
J Med Chem; 2014 Jun; 57(12):5293-305. PubMed ID: 24870926
[TBL] [Abstract][Full Text] [Related]
15. Identification and development of 2-methylimidazo[1,2-a]pyridine-3-carboxamides as Mycobacterium tuberculosis pantothenate synthetase inhibitors.
Samala G; Nallangi R; Devi PB; Saxena S; Yadav R; Sridevi JP; Yogeeswari P; Sriram D
Bioorg Med Chem; 2014 Aug; 22(15):4223-32. PubMed ID: 24953948
[TBL] [Abstract][Full Text] [Related]
16. Development of 3-phenyl-4,5,6,7-tetrahydro-1H-pyrazolo[4,3-c]pyridine derivatives as novel Mycobacterium tuberculosis pantothenate synthetase inhibitors.
Samala G; Devi PB; Nallangi R; Yogeeswari P; Sriram D
Eur J Med Chem; 2013 Nov; 69():356-64. PubMed ID: 24077526
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and tuberculostatic activity of some derivatives of imidazo [4, 5-b]pyridine-1-carboxylic acid.
Bukowski L
Pol J Pharmacol Pharm; 1984; 36(6):683-8. PubMed ID: 6442935
[TBL] [Abstract][Full Text] [Related]
18. Exploring acyclic nucleoside analogues as inhibitors of Mycobacterium tuberculosis thymidylate kinase.
Familiar O; Munier-Lehmann H; Negri A; Gago F; Douguet D; Rigouts L; Hernández AI; Camarasa MJ; Pérez-Pérez MJ
ChemMedChem; 2008 Jul; 3(7):1083-93. PubMed ID: 18418833
[TBL] [Abstract][Full Text] [Related]
19. Novel indanyl-substituted imidazo[1,2-a]pyridines as potent reversible inhibitors of the gastric H+/K+-ATPase.
Zimmermann PJ; Buhr W; Brehm C; Palmer AM; Feth MP; Senn-Bilfinger J; Simon WA
Bioorg Med Chem Lett; 2007 Oct; 17(19):5374-8. PubMed ID: 17723299
[TBL] [Abstract][Full Text] [Related]
20. Development of a simple assay protocol for high-throughput screening of Mycobacterium tuberculosis glutamine synthetase for the identification of novel inhibitors.
Singh U; Panchanadikar V; Sarkar D
J Biomol Screen; 2005 Oct; 10(7):725-9. PubMed ID: 16129778
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
